1. Market Research
  2. > Pathology
About 100 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Wound Care Market (by Product Type, Applications, Wound Type, Region and Company), Major Deals, Size, Share, Trends - Forecast to 2026

  • $ 2190
  • November 2019
  • 218 pages

lymphoma.

  • Dermatological Condition
  • Healthcare
  • Lymphoma
  • Wound Care
  • World

Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • November 2018
  • 108 pages

This box warning has not been removed by the FDA or by the European Agency [despite evidence against the link between TCIs and lymphoma]. "

  • Dermatological Condition
  • Healthcare
  • Hospital
  • Pathology
  • Therapy

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • December 2018
  • 106 pages

FURTHERMORE, PSORIASIS IS COMMONLY ASSOCIATED WITH NAIL DISEASE, CARDIOVASCULAR DISEASE (CVD), LYMPHOMA, AND INFLAMMATORY BOWEL DISEASE (IBD) (MENTER ET AL., 2009).

  • Dermatological Condition
  • Healthcare
  • Lymphoma
  • Pathology
  • Therapy

Axillary Hyperhidrosis - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 53 pages

The Merger would create a pharmaceutical company focused on developing novel and differentiated prescription therapies addressing unmet patient needs in hyperhidrosis, cutaneous Tcell lymphoma, psoriasis, and other debilitating dermatologic disorders.

  • Dermatological Condition
  • Therapy
  • United States
  • Allergan plc
  • Bodor Laboratories, Inc.

Dermatology Drugs Market Global Briefing 2018

  • $ 1000
  • January 2018
  • 29 pages

The dermatology drugs market includes medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hai ...

  • Dermatological Condition
  • Dermatological Treatment
  • Lymphoma
  • Allergan plc
  • Galderma S.A.

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

  • $ 4995
  • September 2018
  • 141 pages

However, Humira is packaged with a boxed warning relating to an increased risk of severe infections, such as tuberculosis and bacterial sepsis, and an increased risk of malignancy, such as lymphomas, for patients taking this drug.

  • Autoimmune Disease
  • Dermatological Condition
  • Dermatological Treatment
  • Lymphoma
  • Therapy

The Global Dermatology Market to 2028

  • $ 2849
  • June 2018
  • 180 pages

The global dermatological (prescription) drugs market was valued at $38.4bn in 2017, GMR Data forecast that this will rise to $44.1bn across 2018. The third in a series of biennial Dermatology reports ...

  • Autoimmune Disease
  • Dermatological Condition
  • Dermatology
  • Lymphoma
  • Therapy

World Prescription Dermatological Drugs Market, 10th Edition

  • $ 4200
  • June 2017
  • 414 pages

ITS PRINCIPAL INDICATIONS ARE FOR CENTRAL NERVOUS SYSTEM MALIGNANCIES, LYMPHOMAS, MELANOMA, AND GASTROINTESTINAL TUMORS.

  • Antifungal
  • Dermatological Condition
  • Lymphoma
  • Therapy
  • World

Plaque Psoriasis: Epidemiology Forecast to 2027

  • $ 3995
  • December 2018
  • 29 pages

Plaque Psoriasis: Epidemiology Forecast to 2027 Summary Epidemiologists forecast an increase in the one-year diagnosed prevalent cases of plaque psoriasis in the 7MM, from 16,030,747 cases in 2017 to ...

  • Dermatological Condition
  • Epidemiology
  • Lymphoma
  • Pathology
  • Forecast

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies

  • $ 2995
  • February 2018
  • 106 pages

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies Summary Cosmeceutical products are characterized as cosmetic products with biologically ...

  • Dermatological Condition
  • Personal Hygiene
  • Beiersdorf AG
  • Estee Lauder Companies Inc.
  • L'Oreal S.A.

A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market

  • $ 2995
  • September 2017
  • 63 pages

Frey' s syndrome Focal gustatory sweating may develop after operations or in patients with lesions of the parotid salivary gland with damage to the facial nerve Chronic infections Endocarditis, Tuberculosis and HIV infection Malignancy Lymphoma, Branchial carcinoma.

  • Dermatological Condition
  • Pathology
  • Therapy
  • Brickell Biotech, Inc.
  • Miramar Labs, Inc.

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

  • $ 4995
  • July 2017
  • 136 pages

In addition, the reported lymphoma cases were no greater than the expected rate in the general population (Munzenberger and Montejo, 2007).

  • Autoimmune Disease
  • Dermatological Condition
  • Dermatology
  • Lymphoma
  • Therapy

Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • June 2017
  • 1 pages

Aggressive lymphomas.

  • Dermatological Condition
  • Dermatology
  • Lymphoma
  • Pharmaceutical
  • Therapy

Global Atopic Dermatitis Drugs Market 2017-2021

  • $ 2500
  • January 2017
  • 68 pages

This warning was issued after reports emerged of children and adults developing cancer (skin cancers and lymphomas) after using these medications.

  • Dermatological Condition
  • Lymphoma
  • Bayer AG
  • Mylan Inc.
  • Valeant Pharmaceuticals International, Inc.

Pruritus Global Clinical Trials Review, H1, 2020

  • $ 2500
  • May 2020
  • 323 pages

Feb ##, 2020: Elorac to present Naloxone Lotion Phase III study update at the ##th World Congress of Cutaneous Lymphomas in Barcelona Elorac, Inc., a biopharmaceutical company focused on developing best-in-class, innovative, proprietary drugs, announced that Scott Phillips, M. D., Sr.

  • Clinical Trial
  • Dermatological Condition
  • Lymphoma
  • Pharmaceutical
  • Therapy

C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 60 pages

MF and SS are the most common subtypes of cutaneous Tcell lymphoma (CTCL).

  • Dermatological Condition
  • Lymphoma
  • Protein Therapy
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

C-C Chemokine Receptor Type 4 - Pipeline Review, H1 2020

  • $ 3500
  • March 2020
  • 65 pages

MF and SS are the most common subtypes of cutaneous Tcell lymphoma (CTCL).

  • Dermatological Condition
  • Lymphoma
  • Protein Therapy
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

AB Science SA (AB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 77 pages

About masitinib ##/ ##/ 2018: EPFL: Attacking lymphoma at the source The efficacy of target specific therapies in lymphoma is limited to subgroups of patients.

  • Dementia
  • Dermatological Condition
  • Lymphoma
  • Therapy
  • AB Science SA

Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018
  • 79 pages

The efficacy of target specific therapies in lymphoma is limited to subgroups of patients.

  • Dementia
  • Dermatological Condition
  • Lymphoma
  • Therapy
  • AB Science SA

Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth

  • $ 4995
  • May 2016
  • 144 pages

In addition, the reported lymphoma cases were no greater than the expected rate in the general population (Munzenberger and Montejo, 2007).

  • Dermatological Condition
  • Dermatology
  • Lymphoma
  • Therapy
  • Biologics, Inc.

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on